Product NDC: | 53964-001 |
Proprietary Name: | TEPADINA |
Non Proprietary Name: | THIOTEPA |
Active Ingredient(s): | 15 mg/1 & nbsp; THIOTEPA |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 53964-001 |
Labeler Name: | ADIENNE SA |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
Start Marketing Date: | 20110405 |
Package NDC: | 53964-001-01 |
Package Description: | 1 VIAL, GLASS in 1 BOX (53964-001-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS |
NDC Code | 53964-001-01 |
Proprietary Name | TEPADINA |
Package Description | 1 VIAL, GLASS in 1 BOX (53964-001-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS |
Product NDC | 53964-001 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | THIOTEPA |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20110405 |
Marketing Category Name | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
Labeler Name | ADIENNE SA |
Substance Name | THIOTEPA |
Strength Number | 15 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |